Clinical Trial Update: Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjuvant docetaxel after radical radiotherapy in prostate cancer; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Scandinavian Prostate Cancer Group | Conditions: Prostate Cancer | Phase 3 | Status: UNKNOWN